FLJ42393: A Potential Drug Target and Biomarker (G401105)

Target Name: FLJ42393

NCBI ID: G401105

FLJ42393

Other Name(s): Uncharacterized LOC401105 | AVPC1948 | uncharacterized LOC401105

FLJ42393: A Potential Drug Target and Biomarker

FLJ42393 is a protein that is expressed in various tissues and cells in the human body. Its function is not well understood, but it is known to be involved in several cellular processes. According to research, FLJ42393 may be a drug target and biomarker.

The FLJ42393 gene

FLJ42393 is a gene that is located on chromosome 16 at position 252. It encodes a protein that is 42 amino acids long. The protein has several unique features that make it stand out.

One of the most notable features of FLJ42393 is its unique structure. The protein has a unique topology, with a distinct N-terminus and a unique C-terminus. The N-terminus has a conserved region that is involved in protein-protein interactions, while the C-terminus has a unique region that is involved in carbohydrate binding.

Another feature of FLJ42393 is its expression. The protein is expressed in various tissues and cells in the human body, including the brain, heart, and gastrointestinal tract. This suggests that it may be involved in a variety of cellular processes that are relevant to these tissues.

The potential drug target

FLJ42393 has been identified as a potential drug target due to its unique structure and expression. The protein has been shown to interact with several different proteins, including the protein tyrosine kinase (PTK) kinase. This suggests that FLJ42393 may be involved in a variety of cellular processes that are related to protein function and interactions.

The biomarker potential

FLJ42393 has also been identified as a potential biomarker for several diseases. For example, it has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This suggests that FLJ42393 may be a useful biomarker for these diseases and may be targeted by drugs that are designed to treat these conditions.

The future of FLJ42393 research

FLJ42393 is an intriguing protein that has the potential to be a drug target and biomarker. Further research is needed to fully understand its function and to determine its potential as a drug.

In conclusion, FLJ42393 is a protein that is expressed in various tissues and cells in the human body. Its unique structure and expression make it an intriguing candidate for drug targeting and biomarker development. Further research is needed to fully understand its function and potential as a drug.

Protein Name: Uncharacterized LOC401105

The "FLJ42393 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FLJ42393 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets